Shanghai Rendu Biotechnology Co. Ltd. A
医疗健康 · 诊断与研究
Shanghai Rendu Biotechnology Co., Ltd. engages in the research, development, production, and sales of RNA molecular diagnostic technology and products. It offers products in the areas of reproductive health, bloodborne infections, respiratory infections, enterovirus infections, cancer early detection, and other areas; and AutoSAT, SuperSAT, and ultrasonic homogenizer. The company was founded in 2007 and is based in Shanghai, China.
MARKET 市值 1.94B CNY PE 138.7x
52W ¥40.28 – ¥62.36
EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG — 营收 YoY 3.4%
▲ ROE 1.5% 营业利润率 6.0% 净利润率 8.5%
ANALYST 股息率 2.39%